156 related articles for article (PubMed ID: 10773752)
1. Relationship of lipoprotein(a) and its phenotypes with the albumin excretion rate in diabetic patients: a multivariate analysis.
Hernández C; Chacón P; Martí R; García-Pascual L; Mesa J; Simó R
Nephron; 2000 May; 85(1):27-33. PubMed ID: 10773752
[TBL] [Abstract][Full Text] [Related]
2. Relationship between lipoprotein(a) phenotypes and albumin excretion rate in non-insulin-dependent diabetes mellitus: protective effect of 'null' phenotype?
Hernández C; Simó R; Chacón P; Segarra A; López D; Mesa J
Eur J Clin Invest; 1997 Jun; 27(6):497-502. PubMed ID: 9229230
[TBL] [Abstract][Full Text] [Related]
3. Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patients.
Hernández C; Chacón P; García-Pascual L; Mesa J; Simó R
Thromb Res; 2000 Jul; 99(2):119-27. PubMed ID: 10946085
[TBL] [Abstract][Full Text] [Related]
4. Biological variation of lipoprotein(a) in a diabetic population. Analysis of the causes and clinical implications.
Hernández C; Francisco G; Chacón P; Mesa J; Simó R
Clin Chem Lab Med; 2003 Aug; 41(8):1075-80. PubMed ID: 12964817
[TBL] [Abstract][Full Text] [Related]
5. Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.
Lutale JJ; Thordarson H; Abbas ZG; Vetvik K
BMC Nephrol; 2007 Jan; 8():2. PubMed ID: 17224056
[TBL] [Abstract][Full Text] [Related]
6. Albuminuria in nondiabetic relatives of IDDM patients with and without diabetic nephropathy.
Fagerudd JA; Pettersson-Fernholm KJ; Riska MK; Grönhagen-Riska C; Groop PH
Kidney Int; 2000 Sep; 58(3):959-65. PubMed ID: 10972659
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients.
Clodi M; Oberbauer R; Bodlaj G; Hofmann J; Maurer G; Kostner K
Metabolism; 1999 Mar; 48(3):369-72. PubMed ID: 10094115
[TBL] [Abstract][Full Text] [Related]
8. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.
Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521
[TBL] [Abstract][Full Text] [Related]
9. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
Lehmann R; Spinas GA
Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
[TBL] [Abstract][Full Text] [Related]
10. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
[TBL] [Abstract][Full Text] [Related]
11. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
[TBL] [Abstract][Full Text] [Related]
12. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
Ellis D; Lloyd C; Becker DJ; Forrest KY; Orchard TJ
Am J Kidney Dis; 1996 Jun; 27(6):809-18. PubMed ID: 8651245
[TBL] [Abstract][Full Text] [Related]
13. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
[TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
15. Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes.
Fyhrquist F; Tiitu A; Saijonmaa O; Forsblom C; Groop PH;
J Intern Med; 2010 Mar; 267(3):278-86. PubMed ID: 19563389
[TBL] [Abstract][Full Text] [Related]
16. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
Hernández C; Chacón P; García-Pascual L; Simó R
Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria.
De Cosmo S; Bacci S; Piras GP; Cignarelli M; Placentino G; Margaglione M; Colaizzo D; Di Minno G; Giorgino R; Liuzzi A; Viberti GC
Diabetologia; 1997 Oct; 40(10):1191-6. PubMed ID: 9349601
[TBL] [Abstract][Full Text] [Related]
18. Relation of apolipoprotein (a) phenotypes to diabetic retinopathy in elderly type 2 diabetes.
Suzuki T; Oba K; Igari Y; Matsumura N; Inuzuka Y; Kigawa Y; Matsuura Y; Ajiro Y; Okazaki K; Nakano H
J Nippon Med Sch; 2002 Feb; 69(1):31-8. PubMed ID: 11847507
[TBL] [Abstract][Full Text] [Related]
19. [An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].
Galovičová A; Lazúrová I; Petrášová D
Vnitr Lek; 2012 Nov; 58(11):825-9. PubMed ID: 23256827
[TBL] [Abstract][Full Text] [Related]
20. Urinary albumin to osmolality ratio predicts 24-hour urine albumin excretion in diabetes mellitus.
Gyamlani GG; Bergstralh EJ; Slezak JM; Larson TS
Am J Kidney Dis; 2003 Oct; 42(4):685-92. PubMed ID: 14520618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
